Food and Drug Administration (FDA) approved Zepbound (tirzepatide) for chronic weight management in adults, to be used in combination with a reduced-calorie diet and exercise
In leptin-sensitive individuals, this signaling may help prevent the excessive intake of sweet foods
Ongoing monitoring tracks weight loss progress, side effect management, and metabolic parameters
While there are different types of fats, and some are better for us than others, it is not about cutting out all fat from our diets
Even so, the researchers said the findings provide early evidence that the risk may depend on both the formulation and dose of semaglutide drugs
In addition, switching from dulaglutide therapy to injectable semaglutide therapy has a weaker BW-reducing effect than switching from other GLP-1RAs [41]